Clinical Trials

Accrual Status
Limit to SWOG Trials

1028 Results

    View
    Status Trial Number Title Activated Closed Accrual Phase Published
    Closed S1900C LUNGMAP S1900C: STK11 - Talazoparib Plus Avelumab 1/16/2020 12/18/2020 100%
    Closed S1900B LUNGMAP S1900B: RET Fustion Positive - LOXO-292 2/10/2020 5%
    Open S1933 A Pilot Study of Hypofractionated Radiotherapy Followed by Atezolizumab Consolidation in Stage II or III NSCLC Patients with Borderline Performance Status 6/15/2020 79%
    Closed S1929 Phase II Study of Maintenance Atezolizumab Versus Atezolizumab in Combination with Talazoparib in Patients with SLFN11 Positive Extensive Stage Small Cell Lung Cancer (SCLC) 6/15/2020 12/15/2022 100%
    Open S2000 A randomized phase 2 trial of encorafenib + binimetinib + nivolumab vs ipilimumab + nivolumab in BRAFV600-mutant melanoma brain metastases 9/23/2020 94%
    Open S2001 Parallel Randomized Phase II Clinical Trial of Olaparib + Pembrolizumab vs. Olaparib as Maintenance Therapy in Two Cohorts of Metastatic Pancreatic Cancer Patients with DNA Damage Repair Defects 12/4/2020 57%
    Open S2007 Sacituzumab Govitecan for HER2-Neg Breast Cancer and Brain Metastases 12/15/2020 55%
    Open S1900E LUNGMAP S1900E: KRAS Targeted Therapy Sub-Study 4/2/2021 97%
    Open S2005 A Phase II Randomized Study of Ibrutinib and Rituximab with or without Venetoclax in Previously Untreated Waldenstrom's Macroglobulinemia (WM) / Lymphoplasmacytic Lymphoma (LPL) 6/24/2021 3%
    Closed S1934 NASSIST 9/9/2021 3/1/2023 0%
    Closed S2011 SWOG GAPTrial 10/6/2021 11/15/2023 3%
    Open S2104 A Phase II Randomized Trial of Postoperative Adjuvant Capecitabine and Temozolimide versus Observation in High-Risk Pancreatic Neuroendocrine Tumors 10/14/2021 29%
    Open S2107 Randomized Phase II Trial of Encorafenib and Cetuximab with or Without Nivolumab (NSC #748726) for Patients with Previously Treated, Microsatellite Stable, BRAFV600E Metastatic and/or Unresectable… 6/6/2022 76%
    Closed S1900F A Randomized Phase II Study of Carboplatin and Pemetrexed With Or Without Selpercatinib In Patients With Non-Squamous RET Positive Stage IV NSCLC and Progression of Disease On Prior RET Directed Therapy 7/25/2022 6/27/2023 0%
    Open S2200 S2200, A Phase II Randomized Trial of Cabozantinib with or Without Atezolizumab in Patients with Advanced Papillary Renal Cell Carcinoma: PAPMET2 9/19/2022 8%
    Open S2101 BiCaZO - iMATCH pilot 10/14/2022 17%
    Open S2114 Ph II consolidation therapy following CD19 CAR-T for R/R DLBCL or Gr III FL 2/23/2023 12%
    Open EAY191-S3 ComboMATCH S3 3/6/2023 3%
    Open S1900G Comparing Combinations of Targeted Drugs for Advanced NSCLC that has EGFR and MET Gene Changes 4/3/2023 17%
    Open S2207 Study Adding Drugs to Usual Treatment for Large B-Cell Lymphoma That Returned or Did Not Respond to Treatment 6/30/2023 6%
    Scroll Table